18553

543980

JLHL

img img img img
No Data Available

Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

JUPITER LIFE LINE HOSP L Share Price Today

JUPITER LIFE LINE HOSP L is currently trading at ₹1308, down by ₹7.19 from the previous close. The stock touched an intraday high of ₹1325.30 and a low of ₹1301.30 during the latest trading session. Over the past one year, JUPITER LIFE LINE HOSP L has delivered a loss of 12.51%, while the stock has gained 5.92% in the last one month.

JUPITER LIFE LINE HOSP L performance

Today’s low Today’s high
₹ 1301.30 ₹ 1325.30
₹ 1307.50
52 week low 52 week high
₹ 1178.00 ₹ 1625.00
₹ 1307.50
Open Price ₹ 1308.70
Prev. Close ₹ 1315.20
Volume (Shares) 17893.00
Total traded value ₹ 233.95
Upper Circuit ₹ 1578.20
Lower Circuit ₹ 1052.20
info

Investment Returns

Over 1 Month 5.92% Over 3 Months 0.22% Over 6 Months -8.71% Over 1 Year -12.51%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

JUPITER LIFE LINE HOSP L fundamentals


  • Market cap (Cr) 8,572.80
  • P/E Ratio (TTM) 44.83
  • Beta 0.26
  • Book Value / share 245.18
  • Return on equity 13.85%
  • EPS (TTM) 29.69
  • Dividend yield 0.08%
  • Net profit/quarter (Cr) 49.20
info icon alternate text
  • Market cap (Cr) 8,580.30
  • P/E Ratio (TTM) 44.83
  • Beta 0.24
  • Book Value / share 245.18
  • Return on equity 13.85%
  • EPS (TTM) 29.69
  • Dividend yield 0.08%
  • Net profit/quarter (Cr) 49.20
info icon alternate text

JUPITER LIFE LINE HOSP L Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition
info-icon
Revenue
Net income
Particulars MAR 2026 (Values in Cr)
Revenue 312.42
Operating Expense 256.98
Net Profit 49.20
Net Profit Margin (%) 15.74
Earnings Per Share (EPS) 7.51
EBITDA 88.23
Effective Tax Rate (%) 24.93
Particulars DEC 2025 (Values in Cr)
Revenue 291.40
Operating Expense 235.26
Net Profit 44.28
Net Profit Margin (%) 15.19
Earnings Per Share (EPS) 6.75
EBITDA 79.22
Effective Tax Rate (%) 25.90
Particulars SEP 2025 (Values in Cr)
Revenue 315.82
Operating Expense 256.64
Net Profit 54.60
Net Profit Margin (%) 17.28
Earnings Per Share (EPS) 8.33
EBITDA 90.12
Effective Tax Rate (%) 22.53
Particulars JUN 2025 (Values in Cr)
Revenue 277.99
Operating Expense 230.07
Net Profit 43.29
Net Profit Margin (%) 15.57
Earnings Per Share (EPS) 6.60
EBITDA 80.42
Effective Tax Rate (%) 28.74
Particulars MAR 2025 (Values in Cr)
Revenue 273.77
Operating Expense 219.08
Net Profit 44.45
Net Profit Margin (%) 16.23
Earnings Per Share (EPS) 6.78
EBITDA 79.16
Effective Tax Rate (%) 28.05
Particulars MAR 2026 (Values in Cr)
Revenue 1197.62
Operating Expense 978.96
Net Profit 191.38
Net Profit Margin (%) 15.98
Earnings Per Share (EPS) 29.19
EBITDA 338.01
Effective Tax Rate (%) 25.39
Particulars MAR 2025 (Values in Cr)
Revenue 1060.07
Operating Expense 841.80
Net Profit 184.70
Net Profit Margin (%) 17.42
Earnings Per Share (EPS) 28.17
EBITDA 297.36
Effective Tax Rate (%) 25.02
Particulars MAR 2024 (Values in Cr)
Revenue 914.57
Operating Expense 736.44
Net Profit 151.95
Net Profit Margin (%) 16.61
Earnings Per Share (EPS) 24.89
EBITDA 253.00
Effective Tax Rate (%) 25.44
Particulars MAR 2023 (Values in Cr)
Revenue 787.32
Operating Expense 639.61
Net Profit 107.21
Net Profit Margin (%) 13.61
Earnings Per Share (EPS) 20.58
EBITDA 215.20
Effective Tax Rate (%) 32.52
Particulars MAR 2022 (Values in Cr)
Revenue 657.28
Operating Expense 555.32
Net Profit 84.67
Net Profit Margin (%) 12.88
Earnings Per Share (EPS) 16.65
EBITDA 162.60
Effective Tax Rate (%) 19.90
Particulars MAR 2025 (Values in Cr)
Book Value / Share 206.85
ROE % 15.32
ROCE % 18.33
Total Debt to Total Equity 0.16
EBITDA Margin 25.78
Particulars MAR 2024 (Values in Cr)
Book Value / Share 178.30
ROE % 23.02
ROCE % 22.10
Total Debt to Total Equity 0.31
EBITDA Margin 24.61
Particulars MAR 2023 (Values in Cr)
Book Value / Share 64.70
ROE % 22.12
ROCE % 21.07
Total Debt to Total Equity 1.46
EBITDA Margin 23.48
Particulars MAR 2022 (Values in Cr)
Book Value / Share 57.36
ROE % 19.20
ROCE % 16.66
Total Debt to Total Equity 1.73
EBITDA Margin 21.45
Particulars MAR 2021 (Values in Cr)
Book Value / Share 46.98
ROE % -0.97
ROCE % 6.91
Total Debt to Total Equity 1.47
EBITDA Margin 14.66
Particulars MAR 2025 (Values in Cr)
Book Value / Share 216.96
ROE % 13.85
ROCE % 18.11
Total Debt to Total Equity 0.05
EBITDA Margin 28.05
Particulars MAR 2024 (Values in Cr)
Book Value / Share 189.92
ROE % 17.77
ROCE % 22.13
Total Debt to Total Equity 0.17
EBITDA Margin 27.66
Particulars MAR 2023 (Values in Cr)
Book Value / Share 82.28
ROE % 27.01
ROCE % 26.40
Total Debt to Total Equity 0.78
EBITDA Margin 27.33
Particulars MAR 2022 (Values in Cr)
Book Value / Share 64.30
ROE % 29.09
ROCE % 23.16
Total Debt to Total Equity 1.00
EBITDA Margin 24.74
Particulars MAR 2021 (Values in Cr)
Book Value / Share 49.80
ROE % 6.77
ROCE % 9.02
Total Debt to Total Equity 1.07
EBITDA Margin 15.85
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 488.66
Total Assets 1904.88
Total Liabilities 1904.88
Total Equity 1356.24
Share Outstanding 6
Price to Book Ratio 7.34
Return on Assets (%) 10.15
Return on Capital (%) 11.5
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 301.25
Total Assets 1281.33
Total Liabilities 1281.33
Total Equity 1168.73
Share Outstanding 6
Price to Book Ratio 6.31
Return on Assets (%) 13.78
Return on Capital (%) 15.11
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 134.46
Total Assets 985.53
Total Liabilities 985.53
Total Equity 363.91
Share Outstanding 5
Price to Book Ratio 0.00
Return on Assets (%) 7.39
Return on Capital (%) 8.76
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 103.36
Total Assets 908.69
Total Liabilities 908.69
Total Equity 288.43
Share Outstanding 5
Price to Book Ratio 0.00
Return on Assets (%) 5.62
Return on Capital (%) 6.52
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 19.43
Total Assets 788.90
Total Liabilities 788.90
Total Equity 246.44
Share Outstanding 5
Price to Book Ratio 0.00
Return on Assets (%) -0.29
Return on Capital (%) -0.34
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 487.75
Total Assets 1710.34
Total Liabilities 1710.34
Total Equity 1422.54
Share Outstanding 6
Price to Book Ratio 7.34
Return on Assets (%) 10.79
Return on Capital (%) 12.33
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 297.19
Total Assets 1360.59
Total Liabilities 1360.59
Total Equity 1245.25
Share Outstanding 6
Price to Book Ratio 6.31
Return on Assets (%) 11.16
Return on Capital (%) 12.2
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 133.30
Total Assets 885.33
Total Liabilities 885.33
Total Equity 465.02
Share Outstanding 5
Price to Book Ratio 0.00
Return on Assets (%) 12.10
Return on Capital (%) 14.06
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 102.15
Total Assets 754.74
Total Liabilities 754.74
Total Equity 328.87
Share Outstanding 5
Price to Book Ratio 0.00
Return on Assets (%) 11.21
Return on Capital (%) 13.01
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 18.46
Total Assets 614.56
Total Liabilities 614.56
Total Equity 253.33
Share Outstanding 5
Price to Book Ratio 0.00
Return on Assets (%) 2.69
Return on Capital (%) 3.22
Particulars MAR 2025 (Values in Cr)
Net Income 257.70
Cash from Operations 320.74
Cash from Investing -208.62
Cash from Financing 300.62
Net change in Cash 345.30
Free Cash Flow 641.47
Particulars MAR 2024 (Values in Cr)
Net Income 195.41
Cash from Operations 164.20
Cash from Investing -246.14
Cash from Financing 128.15
Net change in Cash -3.46
Free Cash Flow 249.49
Particulars MAR 2023 (Values in Cr)
Net Income 128.70
Cash from Operations 195.88
Cash from Investing -94.24
Cash from Financing -51.05
Net change in Cash 31.09
Free Cash Flow 273.12
Particulars MAR 2022 (Values in Cr)
Net Income 77.11
Cash from Operations 145.59
Cash from Investing -85.24
Cash from Financing 32.20
Net change in Cash 83.92
Free Cash Flow 237.32
Particulars MAR 2021 (Values in Cr)
Net Income 1.55
Cash from Operations 133.20
Cash from Investing -295.84
Cash from Financing 184.29
Net change in Cash 11.85
Free Cash Flow 374.78
Particulars MAR 2025 (Values in Cr)
Net Income 246.34
Cash from Operations 282.26
Cash from Investing -173.28
Cash from Financing 301.83
Net change in Cash 348.43
Free Cash Flow 562.67
Particulars MAR 2024 (Values in Cr)
Net Income 203.82
Cash from Operations 159.47
Cash from Investing -238.03
Cash from Financing 121.88
Net change in Cash -6.36
Free Cash Flow 235.82
Particulars MAR 2023 (Values in Cr)
Net Income 158.88
Cash from Operations 217.32
Cash from Investing -129.65
Cash from Financing -23.22
Net change in Cash 31.14
Free Cash Flow 260.58
Particulars MAR 2022 (Values in Cr)
Net Income 105.71
Cash from Operations 150.96
Cash from Investing -68.92
Cash from Financing 9.66
Net change in Cash 83.08
Free Cash Flow 217.31
Particulars MAR 2021 (Values in Cr)
Net Income 17.54
Cash from Operations 123.49
Cash from Investing -78.21
Cash from Financing -23.42
Net change in Cash 11.50
Free Cash Flow 145.57
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
APOLLO HOSPITALS ENTERPRISE LT 8303.55 61.03 12.60 119392.31 6680.00 8490.30
FORTIS MALAR HOSPITALS LIMITED 54.56 24.69 2.97 102.26 40.75 77.00
SHREE PACETRONIX LTD. 141.75 16.92 2.98 53.15 66.10 283.15
TRANSGENE BIOTEK LTD. 3.11 0.00 2.81 23.56 1.83 5.26
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
APOLLO HOSPITALS ENTERPRISE LT 8303.55 79.53 11.98 119392.31 6680.00 8490.30
[-] 0.0 0.0 0.0 0.0 0.0 0.0
CHENNAI MEENAKSHI MULTISPECIAL 38.80 0.00 -9.44 28.98 30.30 57.48
KOVAI MEDICAL CENTER & HOSPITA 5378.20 24.07 4.45 5883.75 5010.00 6725.00

JUPITER LIFE LINE HOSP L shareholding pattern

Holding
33.59%
40.91%
8.47%
17.01%
Name Shares Category
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)

JUPITER LIFE LINE HOSP L Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
1307.50 -0.58 redarrow
red-green-graph indicator
10 Bearish
6 Bullish
  • 5 Days 1314.70
  • 26 Days 1303.10
  • 10 Days 1316.50
  • 50 Days 1292.50
  • 12 Days 1315.50
  • 100 Days 1305.90
  • 20 Days 1308.40
  • 200 Days 1345.10
1317.47 PIVOT
First Support 1303.83 First Resistance 1328.83 Second Support 1292.47 Second Resistance 1342.47 Third Support 1278.83 Third Resistance 1353.83
RSI 51.54 ADX 16.14 MACD 12.41 Williams % R -76.68 Commodity Channel Index (CCI) -4.92
Date 2026-06-05 Week 10161.00 Same Day 11263.00 Month 47997.00
1 Year 0.26 3 Year 0.40
Over 1 Month
5.92% down
Over 1 Year
-12.51% down
Over 3 Months
0.22% down
Over 3 Years
6.71% down
Over 6 Months
-8.71% down
Over 5 Years
0.00% down

JUPITER LIFE LINE HOSP L Corporate Actions

Dividend date Dividend amount Dividend type Record date Instrument type
22 May 2026 1.0 Interim 22 May 2026 Equity shares
04 Jul 2025 1.0 Final 04 Jul 2025 Equity shares
02 Aug 2024 1.0 Final 02 Aug 2024 Equity shares
Dividend date Dividend amount Dividend type Record date Instrument type
22 May 2026 1.0 Interim 22 May 2026 Equity shares
04 Jul 2025 1.0 Final 04 Jul 2025 Equity shares
02 Aug 2024 1.0 Final 02 Aug 2024 Equity shares

Top Gainers

Top Losers

stock
Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Jupiter Life Line Hospitals Ltd?

Answer Field

Jupiter Life Line Hospitals Ltd share price is for NSE ₹ 1,308.00 & for BSE ₹ 1,319.00 as on Jun 05 2026 03:29 PM.

What is the Market Cap of Jupiter Life Line Hospitals Ltd Share?

Answer Field

The market cap of Jupiter Life Line Hospitals Ltd for NSE ₹ 0.00 & for BSE ₹ 0.00 as on Jun 05 2026 03:29 PM.

What is the 52 Week High and Low of Jupiter Life Line Hospitals Ltd?

Answer Field

The 52 Week High and Low of Jupiter Life Line Hospitals Ltd for NSE is ₹ 1,625.00 and ₹ 1,178.00 and for BSE is ₹ 1,618.15 and ₹ 1,152.05.

What is 1 year return for Jupiter Life Line Hospitals Ltd?

Answer Field

The 1 year returns on the stock has been -12.51%.

What is the P/E Ratio of Jupiter Life Line Hospitals Ltd Share?

Answer Field

As on Jun 05 2026 03:29 PM the price-to-earnings (PE) ratio for Jupiter Life Line Hospitals Ltd share is 44.83.

What is the PB ratio of Jupiter Life Line Hospitals Ltd Share?

Answer Field

As on Jun 05 2026 03:29 PM, the price-to-book (PB) ratio for Jupiter Life Line Hospitals Ltd share is 245.18.

How to Buy Jupiter Life Line Hospitals Ltd Share?

Answer Field

You can trade in Jupiter Life Line Hospitals Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Jupiter Life Line Hospitals Ltd Share on Bajaj Broking App?

Answer Field

To buy Jupiter Life Line Hospitals Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Jupiter Life Line Hospitals Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

close-image

Get Free Demat Account*

+91
close-img

Authorise with OTP

Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59
banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|